Delivery Order SPE2DB22D1017-SPE2DB25FG5QE
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,749.98 firm fixed-price contract is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a medication used in the treatment of osteoporosis. The contract has an ultimate completion date of March 6, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This is a $7,804.29 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML, a medication used to treat osteoporosis. The contract has an ultimate completion date of June 13, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor and holds a significant...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,296.36 contract is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a medical product used in the treatment of various medical conditions. The contract has an ultimate completion date of January 16, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML, a pharmaceutical product, with a ceiling value of $2,601.43 and a performance period ending on July 10, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,856.76 firm fixed-price delivery order contract is for the supply of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML, a medication used in the treatment of osteoporosis. The contract has an ultimate completion date of April 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML, a pharmaceutical product, with a ceiling value of $2,601.43 and a period of performance through June 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,133.88 firm fixed-price delivery order is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a medication used in the treatment of osteoporosis. The contract has an ultimate completion date of January 14, 2025. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,728.88 contract is for the supply of the medication FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML. The contract has an ultimate completion date of July 1, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML, a medication used for the treatment of osteoporosis. The contract has a ceiling value of $4,289.89 and is a firm fixed-price delivery order contract, with a period of performance through May 6, 2025. The contract is not set-aside and is open...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty pharmaceutical product, with a ceiling value of $9,243.97 and a completion date of January 10, 2024. The contract has a firm fixed price pricing type and does not have a set-aside designation, indicating open...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG5QEDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,601.43 firm-fixed-price contract is for the delivery of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML, a medication used in the treatment of osteoporosis. The contract has an ultimate completion date of June 24, 2025 and is not set aside for a specific business category. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This prime contract enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 6/23/25 |